Lifestyle intervention group:Lifestyle intervention
Sponsors
Shanghai tenth people's hospital, Shanghai East Hospital; Tongji University Affilliated East Hospital, Zhejiang Provincial People's Hospital
Conditions
Hyperuricemiaobesitypolycystic ovary syndrome
Phase 1
Unknown Phase
Evaluation of the Effect of SGLT2 Inhibitor Dapagliflozin on Reducing Uric Acid Levels in Overweight or Obese Non-Diabetic Patients with Hyperuricemia.
RecruitingChiCTR2500101751
Start: 2025-03-07Updated: 2025-05-05
A Clinical Intervention Study Investigating Cai's Therapy in the Management of Overweight and Obesity
RecruitingITMCTR2025001431
Start: 2024-01-01Updated: 2025-07-21